Intrinsic Value of S&P & Nasdaq Contact Us

Hyperfine, Inc. HYPR NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
59/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.60
+24%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Hyperfine, Inc. (HYPR) has a negative trailing P/E of -3.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -31.08%.

Criteria proven by this page:

  • VALUE (90/100, Pass) — analyst target implies upside (+24%).
  • Trailing Earnings Yield -31.08% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $1.60 (+24% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 59/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
59/100
SG Score
View full scorecard →
VALUE
90/100
Price-to-Earnings & upside
Proven by this page
FUTURE
79/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
43/100
→ Income
GROWTH
90/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — HYPR

Valuation Multiples
P/E (TTM)-3.2
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio2.79
P/S Ratio7.32
EV/EBITDA-1.7
Per Share Data
EPS (TTM)$-0.38
Book Value / Share$0.44
Revenue / Share$0.14
FCF / Share$-0.31
Yields & Fair Value
Earnings Yield-31.08%
Dividend Yield0.00%
Analyst Target$1.60 (+24%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -2.5 0.00 1.61 0.00 -
2020 -10.8 0.14 3.75 858.00 -
2021 -7.9 7.31 2.74 340.85 -
2022 -0.8 -0.06 0.48 8.68 -
2023 -1.8 0.04 0.95 7.24 -
2024 -1.6 0.16 1.30 4.94 -
2025 -2.6 0.11 2.25 6.80 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.27 $0.00 $-18.79M -
2020 $-0.93 $294K $-23.36M -7944.6%
2021 $-0.92 $1.5M $-64.83M -4333.8%
2022 $-1.03 $6.81M $-72.45M -1063.3%
2023 $-0.62 $11.03M $-44.24M -401%
2024 $-0.56 $12.89M $-40.72M -315.9%
2025 $-0.43 $13.56M $-35.57M -262.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.35 $-0.35 – $-0.34 $20.05M $20.03M – $20.06M 1
2027 $-0.33 $-0.33 – $-0.33 $26M $25.98M – $26.02M 1
2028 $-0.34 $-0.34 – $-0.34 $24.3M $24.28M – $24.32M 1
2029 $-0.29 $-0.29 – $-0.29 $29.4M $29.38M – $29.42M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message